Chausmer A, Ettenberg A
Department of Psychology, University of California, Santa Barbara, 93106, USA.
Pharmacol Biochem Behav. 1999 Feb;62(2):299-305. doi: 10.1016/s0091-3057(98)00165-8.
It has been well established that the presentation of a single reinforced trial in the midst of extinction results in a reinstatement of the previously reinforced operant response. In previous experiments, we have shown that systemically applied raclopride (a selective dopamine D2 receptor antagonist) dose dependently blocked the response-reinstating properties of food reinforcement, while SCH39166 (a selective dopamine D1 receptor antagonist) did not (11). The current experiments investigated the possible role of the nucleus accumbens in these actions of raclopride. In the first of two experiments, hungry rats were trained to traverse a straight runway for food reinforcement, a response that was then weakened through a series of extinction trials. On a single treatment trial, subjects were infused with one of three doses of intraaccumbens raclopride (0.0, 2.5, or 5.0 microg/0.5 microl/side) just prior to a reinforced trial. Twenty-four hours later, a single test trial was run in an unbaited runway. The results demonstrate that the prior day's reinforced trial produced a reinstatement of operant runway performance that was unaltered by intraaccumbens applications of raclopride. Two days later, the same animals were tested in a second experiment investigating the effects of intraaccumbens raclopride on amphetamine-induced locomotion. Subjects were pretreated with 1.0 mg/kg s.c. amphetamine prior to a 90-min locomotor activity session. The following day, subjects were again pretreated with amphetamine, but this time with a challenge dose of raclopride. Results demonstrate that the same raclopride doses that produced no effect in the response-reinstating experiment produced, in the same rats, a dose-dependent attenuation in amphetamine-induced locomotion. These data suggest that dopamine D2 receptors in the nucleus accumbens may not, in and of themselves, be necessary for the response-reinstating effects of food reinforcement.
业已充分证实,在消退过程中呈现单次强化试验会导致先前强化的操作性反应恢复。在先前的实验中,我们已经表明,全身应用雷氯必利(一种选择性多巴胺D2受体拮抗剂)剂量依赖性地阻断了食物强化的反应恢复特性,而SCH39166(一种选择性多巴胺D1受体拮抗剂)则没有(11)。当前的实验研究了伏隔核在雷氯必利这些作用中的可能作用。在两项实验的第一项中,饥饿的大鼠被训练穿过一条直跑道以获得食物强化,然后通过一系列消退试验削弱这种反应。在单次治疗试验中,在强化试验前,给受试者脑室内注入三种剂量之一的雷氯必利(0.0、2.5或5.0微克/0.5微升/侧)。24小时后,在未放置诱饵的跑道上进行单次测试试验。结果表明,前一天的强化试验使操作性跑道表现恢复,而脑室内应用雷氯必利并未改变这一表现。两天后,对同一批动物进行第二项实验,研究脑室内注射雷氯必利对苯丙胺诱导的运动的影响。在90分钟的运动活动期之前,给受试者皮下注射1.0毫克/千克苯丙胺进行预处理。第二天,再次给受试者注射苯丙胺,但这次同时给予雷氯必利的激发剂量。结果表明,在反应恢复实验中无作用的相同雷氯必利剂量,在相同的大鼠中,对苯丙胺诱导的运动产生了剂量依赖性的减弱。这些数据表明,伏隔核中的多巴胺D2受体本身可能并非食物强化的反应恢复效应所必需。